Yasmine Ibrahim

818 total citations
26 papers, 601 citations indexed

About

Yasmine Ibrahim is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yasmine Ibrahim has authored 26 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yasmine Ibrahim's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Moringa oleifera research and applications (2 papers). Yasmine Ibrahim is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Moringa oleifera research and applications (2 papers). Yasmine Ibrahim collaborates with scholars based in Egypt, Saudi Arabia and United States. Yasmine Ibrahim's co-authors include Ayman Geddawy, Yuichiro Suzuki, Asmaa M. A. Bayoumi, Mohamed Mokhtar Mohamed, Al‐Shaimaa F. Ahmed, Nahla Alsayd Bouqellah, Michael Graham Espey, Asmaa Mohamed Abdel‐Aziz, Nataliia V. Shults and Mohamed A. Morsy and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Cardiovascular Research and Plastic & Reconstructive Surgery.

In The Last Decade

Yasmine Ibrahim

24 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasmine Ibrahim Egypt 13 155 140 133 88 76 26 601
Aldo Mancini Italy 14 308 2.0× 222 1.6× 107 0.8× 44 0.5× 32 0.4× 32 824
Chun-Ming Shih Taiwan 11 211 1.4× 364 2.6× 392 2.9× 89 1.0× 37 0.5× 47 850
Ming-liang Cheng China 10 173 1.1× 100 0.7× 57 0.4× 30 0.3× 23 0.3× 22 386
Hang Sun China 15 242 1.6× 163 1.2× 129 1.0× 84 1.0× 17 0.2× 52 624
Hongshan Wei China 15 160 1.0× 289 2.1× 212 1.6× 35 0.4× 85 1.1× 67 658
Ling Mei China 10 103 0.7× 168 1.2× 38 0.3× 21 0.2× 50 0.7× 34 558
Yanying Xu China 9 245 1.6× 263 1.9× 151 1.1× 28 0.3× 19 0.3× 16 688
Wenjing Zai China 16 350 2.3× 251 1.8× 121 0.9× 35 0.4× 35 0.5× 26 712

Countries citing papers authored by Yasmine Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Yasmine Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasmine Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasmine Ibrahim more than expected).

Fields of papers citing papers by Yasmine Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasmine Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasmine Ibrahim. The network helps show where Yasmine Ibrahim may publish in the future.

Co-authorship network of co-authors of Yasmine Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Yasmine Ibrahim. A scholar is included among the top collaborators of Yasmine Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasmine Ibrahim. Yasmine Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Abdel‐Aziz, Asmaa Mohamed, et al.. (2024). Cardioprotective effect of tofisopam against isoprenaline-induced myocardial infarction in rats via modulation of NLRP3\IL-1β\caspase-1 pathway. Immunopharmacology and Immunotoxicology. 46(6). 902–911. 1 indexed citations
4.
Al‐Shar’i, Nizar A., Sandeep Chandrashekharappa, Pran Kishore Deb, et al.. (2023). Synthesis, biological evaluation, and computational investigation of ethyl 2,4,6-trisubstituted-1,4-dihydropyrimidine-5-carboxylates as potential larvicidal agents against Anopheles arabiensis. Journal of Biomolecular Structure and Dynamics. 42(8). 4016–4028. 5 indexed citations
5.
Abdel‐Aziz, Asmaa Mohamed, et al.. (2022). Potential role of carvedilol in intestinal toxicity through NF-κB/iNOS/COX-2/TNF-α inflammatory signaling pathway in rats. Immunopharmacology and Immunotoxicology. 44(4). 613–620. 7 indexed citations
6.
Ibrahim, Yasmine, et al.. (2022). Dose-dependent ameliorating effect of lipoxin A4 on gentamicin-induced nephrotoxicity in rats: The role of TNFα, TGF-β, ICAM-1, and JNK signaling. Chemico-Biological Interactions. 366. 110139–110139. 4 indexed citations
7.
Ibrahim, Yasmine, Mohammed Alorabi, Walaa Yehia Abdelzaher, et al.. (2022). Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats. Biomedicine & Pharmacotherapy. 149. 112870–112870. 52 indexed citations
8.
Morsy, Mohamed A., Yasmine Ibrahim, Sara Mohamed Naguib Abdel Hafez, et al.. (2022). Paeonol Attenuates Hepatic Ischemia/Reperfusion Injury by Modulating the Nrf2/HO-1 and TLR4/MYD88/NF-κB Signaling Pathways. Antioxidants. 11(9). 1687–1687. 23 indexed citations
9.
Ibrahim, Yasmine, et al.. (2021). Molecular mechanisms underlying the effect of diacerein on trichloroacetic acid–induced hepatic pre-neoplastic lesions in rats. Human & Experimental Toxicology. 40(12_suppl). S788–S803. 2 indexed citations
10.
Morsy, Mohamed A., et al.. (2021). Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2. Biomedicine & Pharmacotherapy. 141. 111902–111902. 24 indexed citations
11.
Ibrahim, Mohamed, Walaa Yehia Abdelzaher, Yasmine Ibrahim, et al.. (2020). Diacerein protects rats with liver ischemia/reperfusion damage: Down-regulation of TLR4/ NFκ-B signaling pathway. Biomedicine & Pharmacotherapy. 134. 111063–111063. 29 indexed citations
12.
Abdel‐Aziz, Asmaa Mohamed, et al.. (2020). Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2. European Journal of Pharmacology. 889. 173631–173631. 26 indexed citations
13.
Ibrahim, Yasmine, et al.. (2020). Ameliorating effect of tocilizumab in letrozole induced polycystic ovarian syndrome in rats via improving insulin resistance and down-regulation of VEGF/ANGPT/PDGF. Minia Journal of Medical Research. 31(1). 336–353. 1 indexed citations
14.
15.
Bouqellah, Nahla Alsayd, Mohamed Mokhtar Mohamed, & Yasmine Ibrahim. (2018). Synthesis of eco-friendly silver nanoparticles using Allium sp. and their antimicrobial potential on selected vaginal bacteria. Saudi Journal of Biological Sciences. 26(7). 1789–1794. 44 indexed citations
16.
Ibrahim, Yasmine, et al.. (2018). Serum level of interleukin-13 receptor alpha 2 in infants with biliary atresia – is it of value?. Clinical and Experimental Hepatology. 4(2). 91–96. 3 indexed citations
17.
Ibrahim, Yasmine, et al.. (2017). Docetaxel Reverses Pulmonary Vascular Remodeling by Decreasing Autophagy and Resolves Right Ventricular Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 363(1). 20–34. 16 indexed citations
18.
Geddawy, Ayman, et al.. (2017). Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction. Journal of Translational Internal Medicine. 5(1). 8–17. 130 indexed citations
19.
Wang, Xinhong, et al.. (2016). Carfilzomib reverses pulmonary arterial hypertension. Cardiovascular Research. 110(2). 188–199. 51 indexed citations
20.
Morcos, Michael, Andrea Schlotterer, G Kukudov, et al.. (2008). Rosiglitazone Reduces Angiotensin II and Advanced Glycation End Product-dependent Sustained Nuclear Factor-κB Activation in Cultured Human Proximal Tubular Epithelial Cells. Hormone and Metabolic Research. 40(11). 752–759. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aldo Mancini Breakdown of academic impact, for papers by Chun-Ming Shih Breakdown of academic impact, for papers by Ming-liang Cheng Breakdown of academic impact, for papers by Hang Sun Breakdown of academic impact, for papers by Hongshan Wei Breakdown of academic impact, for papers by Ling Mei Breakdown of academic impact, for papers by Yanying Xu Breakdown of academic impact, for papers by Wenjing Zai
Rankless by CCL
2026